×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AXDX – accelerate diagnostics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AXDX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
03:32 am
axdx
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
11/26
12:06 am
axdx
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/14
03:11 am
axdx
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/9
12:01 am
axdx
Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript [Seeking Alpha]
11/7
07:48 pm
axdx
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
High
Report
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/7
04:05 pm
axdx
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
Medium
Report
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
11/6
02:05 am
axdx
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/29
02:09 am
axdx
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
8/8/2024
04:05 pm
axdx
accelerate diagnostics, inc.
BEAT
Report
3.5%
accelerate diagnostics, inc.
5/8/2024
04:42 pm
axdx
accelerate diagnostics, inc.
MISS
Report
-2.2%
accelerate diagnostics, inc.
3/28/2024
04:05 pm
axdx
accelerate diagnostics, inc.
MISS
Report
-10.2%
accelerate diagnostics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
03:24 pm
axdx
Form SC 13G Accelerate Diagnostics, Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G Accelerate Diagnostics, Filed by: ARMISTICE CAPITAL, LLC
11/7
05:29 pm
axdx
Form 10-Q Accelerate Diagnostics, For: Sep 30
Low
Report
Form 10-Q Accelerate Diagnostics, For: Sep 30
11/7
04:13 pm
axdx
Form 8-K Accelerate Diagnostics, For: Nov 07
Medium
Report
Form 8-K Accelerate Diagnostics, For: Nov 07
9/30
09:15 am
axdx
Form 8-K Accelerate Diagnostics, For: Sep 30
Medium
Report
Form 8-K Accelerate Diagnostics, For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/8
Form 3 Accelerate Diagnostics, For: Aug 06 Filed by: Phillips Jack
26.8%
6/3 Form 4 Accelerate Diagnostics, For: May 30 Filed by: SCHULER JACK W 10.1%
11/8 Accelerate Diagnostics (AXDX) Q3 2019 Earnings Call Transcript [The Motley Fool] 9.5%
9/17 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 9.4%
3/27 Form 4 Accelerate Diagnostics, For: Apr 01 Filed by: Strobeck Matthew 8.6%
10/3 Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes 7.9%
4/15 Accelerate Diagnostics and BioCheck Announce Commercial Supply and Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests 7.9%
3/26 Accelerate Diagnostics Inc (NASDAQ: AXDX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.7%
4/21 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.3%
4/8 Form 8-K Accelerate Diagnostics, For: Dec 20 6.6%
6/3 Form 4 Accelerate Diagnostics, For: May 30 Filed by: SCHULER JACK W 10.1%
11/8 Accelerate Diagnostics (AXDX) Q3 2019 Earnings Call Transcript [The Motley Fool] 9.5%
9/17 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 9.4%
3/27 Form 4 Accelerate Diagnostics, For: Apr 01 Filed by: Strobeck Matthew 8.6%
10/3 Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes 7.9%
4/15 Accelerate Diagnostics and BioCheck Announce Commercial Supply and Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests 7.9%
3/26 Accelerate Diagnostics Inc (NASDAQ: AXDX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.7%
4/21 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.3%
4/8 Form 8-K Accelerate Diagnostics, For: Dec 20 6.6%
TOP News Decliners
3/20
Form 4 Accelerate Diagnostics, For: Mar 18 Filed by: Strobeck Matthew
-29.1%
4/14 Form 4 Accelerate Diagnostics, For: Apr 14 Filed by: SCHULER JACK W -15.6%
5/10 Accelerate Diagnostics, Inc. (AXDX) CEO Lawrence Mehren on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.4%
9/27 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. -8.3%
7/8 Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results -7.5%
3/30 Form 8-K Accelerate Diagnostics, For: Mar 24 -5.9%
2/26 Accelerate Diagnostics Inc (NASDAQ: AXDX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -5.6%
2/27 Q4/2019 12/31/2019 EPS -0.390 ZacksConsensus -0.430 ActVsEst 0.040 - Beat -5.3%
9/16 Sepsis Alliance Raises $250,000+ to Save Lives from Sepsis, the 3rd Leading Cause of Death in the U.S. -4.8%
10/25 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.7%
4/14 Form 4 Accelerate Diagnostics, For: Apr 14 Filed by: SCHULER JACK W -15.6%
5/10 Accelerate Diagnostics, Inc. (AXDX) CEO Lawrence Mehren on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.4%
9/27 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. -8.3%
7/8 Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results -7.5%
3/30 Form 8-K Accelerate Diagnostics, For: Mar 24 -5.9%
2/26 Accelerate Diagnostics Inc (NASDAQ: AXDX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -5.6%
2/27 Q4/2019 12/31/2019 EPS -0.390 ZacksConsensus -0.430 ActVsEst 0.040 - Beat -5.3%
9/16 Sepsis Alliance Raises $250,000+ to Save Lives from Sepsis, the 3rd Leading Cause of Death in the U.S. -4.8%
10/25 Accelerate Diagnostics Inc (NASDAQ: AXDX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: